GlassScriptPhysician profile
Gregory Artz
NPI 1962626671
$4,966.01
in general payments reported to CMS, 2019-2025
15 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $681 · 2021: $730 · 2022: $667 · 2023: $702 · 2024: $1,466 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,801.17 | 2022-2025 | Nim Vital, Accuguide |
| Intersect Ent, INC. | $1,509.23 | 2019-2022 | |
| Advanced Bionics, LLC | $381.43 | 2019-2022 | |
| Stryker Corporation | $246.05 | 2022-2025 | Scopis Ent, Core, Audion Et Dilation System |
| Acclarent, INC | $240.35 | 2019-2022 | |
| Cochlear Americas | $195.98 | 2020-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Preceptis Medical, INC. | $149.07 | 2020-2021 | |
| Aerin Medical INC. | $142.66 | 2024 | |
| Iotamotion, INC. | $118.05 | 2024 | Iotasoft |
| Med-El Corporation | $70.47 | 2022-2023 | Mi1250 Synchrony 2 Flexsoft |
| Biosense Webster, INC. | $32.11 | 2019 | |
| 3nt Medical | $25.81 | 2023 | |
| Genzyme Corporation | $23.28 | 2021 | |
| Alk-Abello, INC | $19.17 | 2020 | |
| Glaxosmithkline, LLC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Artz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.